Skip to main content
SCI logo

SCI — Investor Relations & Filings

Ticker · 4119 ISIN · TW0004119003 TW Manufacturing
Filings indexed 1,697 across all filing types
Latest filing 2019-05-20 Investor Presentation
Country TW Taiwan
Listing TW 4119

SCI Pharmtech, Inc. specializes in the research, development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals. Established in 1987 and originally founded by the Swiss Siegfried Group, the company provides high-quality chemical solutions and custom manufacturing services to leading global pharmaceutical corporations across Europe, North America, and Japan. Its core operations encompass advanced chemical synthesis, process optimization, and large-scale production within GMP-compliant facilities. With a robust R&D infrastructure including specialized laboratories and pilot plants, the company delivers technical excellence in complex chemical processing. SCI Pharmtech maintains a strong focus on quality assurance and international regulatory compliance, positioning itself as a reliable partner for the global healthcare and life sciences sectors.

Recent filings

Filing Released Lang Actions
108年05月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing from a public information observation station showing details about a company's investor presentation meeting, including date, time, location, and links to presentation materials. It specifically mentions '法人說明會' which translates to 'investor presentation' or 'institutional investor meeting'. There is no financial data or report content, only references to presentation materials and meeting details. The document length is short (695 characters), and it serves as an announcement or summary of investor presentations rather than a full report. Therefore, the document fits best under the category 'Investor Presentation' (IP).
2019-05-20 Chinese
公告本公司於5月20日受宏遠證券邀請說明營運概況
Investor Presentation Classification · 95% confidence The document is a short announcement (621 characters) about a scheduled investor presentation (法人說明會) on May 20, 2019, where the company will explain its operational overview. It includes details such as date, time, location, and a note that full financial information can be found elsewhere. There are no actual financial statements or detailed analysis in this text. It is clearly an announcement of an upcoming investor presentation event, not the presentation itself or a financial report. Therefore, the appropriate classification is Investor Presentation (IP). Given the document length and content, confidence is high.
2019-05-17 Chinese
108年第1季海外子公司投資
Interim / Quarterly Report Classification · 95% confidence The document is a brief financial disclosure related to investment in overseas subsidiaries, showing investment amounts, shareholding percentages, and recognized investment gains or losses for a specific quarter (108年1季, which corresponds to Q1 of the 108th year in the Taiwanese calendar). The document length is very short (667 characters) and contains tabular data typical of a quarterly or interim financial report. It is not an announcement of a report publication, nor a certification or a regulatory filing. The content includes substantive financial data for a period shorter than a full fiscal year, consistent with an Interim / Quarterly Report (IR). Q1 2019
2019-05-13 Chinese
108年04月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings and stock transactions by insiders, including directors, managers, and other key personnel. It includes data on shares held, increases, decreases, and trust shares, with specific references to identities such as chairman, vice chairman, general manager, and other executives. The content is focused on insider shareholdings and transactions rather than financial results, management commentary, or corporate governance policies. There is no indication of it being a full annual or quarterly report, earnings release, or any other financial report. The document is not a brief announcement but a detailed insider shareholding disclosure. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is sufficient and the content is consistent with insider shareholding disclosures.
2019-05-10 Chinese
108年04月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders and related parties of the company 旭富製藥科技股份有限公司. It lists the number of shares held by directors, independent directors, managers, and other insiders, including pledged shares and shares held by spouses or minors. The document is focused on insider shareholdings and does not contain financial statements, earnings data, or management discussion. It is not an announcement of a report but a disclosure of insider shareholdings. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives. The document length is 3148 characters, which is consistent with a detailed insider shareholding report rather than a full financial report or announcement. Therefore, the appropriate classification is DIRS with high confidence.
2019-05-10 Chinese
108年第1季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial tables showing changes in equity for a specific fiscal period (民國108年第1季, which corresponds to the first quarter of 2019). It includes line items such as ordinary share capital, capital surplus, legal reserve, special reserve, undistributed earnings, retained earnings, and other comprehensive income. The presence of detailed financial data for a quarterly period indicates this is a financial report for a period shorter than a full fiscal year. The document length is 3515 characters, which is relatively short but contains substantive financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2019
2019-05-10 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.